Replies to post #775 on InVivo Therapeutics Hldgs Corp (fka NVIVQ)

[LifeSciDude]

Thank you rru2s!
Thank you for clearing up some of the nonsense propaganda out there!

So based upon what you have posted one would have to conclude:

The hypothesis that some are putting forth that there will be large numbers of "warrant selling" is pretty baseless and I will assume it is some new tactic by shorts to try and induce people to sell at ridiculously low prices around the current $2.80. The current $2.80 price is absurdly low after both Thursday & Friday's news (IMO at least a dollar per share too low)

The IDE approval news that was released by the company is monumental. However, it was released on a Friday, one day after the HUD release, and therefore is under-realized by investors, many of whom may not have heard either news. Anybody selling shares at such low prices would be foolish, given the relative short trajectory ahead to a doubling. Even before the trial begins, there is great upward potential from here because this hugely positive news really hasn't even been publicized yet through various articles and analyst commentary.

Personal needs aside, in my opinion there is no good reason to sell this when we have a probable $5.00 or better share price coming in a short future horizon.

[nsomniyak]

rru2s - you have painted an incomplete picture.

There is a "free money" trade available to warrant holders once warrants are significantly in the money.

Most warrant holders originally bought "units" consisting of shares + a warrant. It is very simple - SELL the shares you have on the open market and use the proceeds to redeem the warrants with the company. This creates selling pressure in the market as the redemption is off-market (direct to the company). After doing this, the former holder of warrants+shares ends up with the same number of shares at a lower net basis.